- Home
- AMD vs ABBV Comparison
AMD vs ABBV Comparison
Compare AMD & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMD
- ABBV
- Stock Information
- Founded
- AMD 1969
- ABBV 2012
- Country
- AMD United States
- ABBV United States
- Employees
- AMD N/A
- ABBV N/A
- Industry
- AMD Semiconductors
- ABBV Biotechnology: Pharmaceutical Preparations
- Sector
- AMD Technology
- ABBV Health Care
- Exchange
- AMD Nasdaq
- ABBV Nasdaq
- Market Cap
- AMD 285.9B
- ABBV 365.1B
- IPO Year
- AMD 1972
- ABBV N/A
- Fundamental
- Price
- AMD $166.58
- ABBV $206.26
- Analyst Decision
- AMD Buy
- ABBV Buy
- Analyst Count
- AMD 37
- ABBV 21
- Target Price
- AMD $171.56
- ABBV $216.10
- AVG Volume (30 Days)
- AMD 71.0M
- ABBV 4.8M
- Earning Date
- AMD 08-05-2025
- ABBV 07-31-2025
- Dividend Yield
- AMD N/A
- ABBV 3.18%
- EPS Growth
- AMD 107.70
- ABBV N/A
- EPS
- AMD 1.73
- ABBV 2.10
- Revenue
- AMD $29,600,000,000.00
- ABBV $58,328,000,000.00
- Revenue This Year
- AMD $25.76
- ABBV $8.72
- Revenue Next Year
- AMD $18.93
- ABBV $8.14
- P/E Ratio
- AMD $96.10
- ABBV $98.14
- Revenue Growth
- AMD 27.17
- ABBV 6.05
- 52 Week Low
- AMD $76.48
- ABBV $163.81
- 52 Week High
- AMD $186.65
- ABBV $218.66
- Technical
- Relative Strength Index (RSI)
- AMD 50.03
- ABBV 70.21
- Support Level
- AMD $168.50
- ABBV $196.89
- Resistance Level
- AMD $186.65
- ABBV $208.34
- Average True Range (ATR)
- AMD 6.83
- ABBV 3.95
- MACD
- AMD -1.68
- ABBV 1.06
- Stochastic Oscillator
- AMD 30.43
- ABBV 89.96
About AMD Advanced Micro Devices Inc.
Advanced Micro Devices designs a variety of digital semiconductors for markets such as PCs, gaming consoles, data centers, industrial, and automotive applications. AMD's traditional strength was in central processing units and graphics processing units used in PCs and data centers. Additionally, the firm supplies the chips found in prominent game consoles such as the Sony PlayStation and Microsoft Xbox. In 2022, the firm acquired field-programmable gate array leader Xilinx to diversify its business and augment its opportunities in key end markets such as data center and automotive.
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).